Basic Research
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 28, 2006; 12(8): 1219-1224
Published online Feb 28, 2006. doi: 10.3748/wjg.v12.i8.1219
Table 1 Pancreatic injury in control (CONT) mice and mice treated with cerulein (CER)
CONTCER
Serum amylase (UI/L)1582 [1236 - 1850]19528 [16369 - 26457]P < 0.0001
Pancreatic water content (% wet weight)0.74 [0.71 – 0.76]0.80 [0.78 - 0.83]P < 0.0001
Pancreatic MPO activity (U/mg tissue dry weight)322 [125 - 456]2738 [1978 - 3245]P = 0.0002
Pancreatic necrosis (%)1.26 [0.5 – 2.3]27.7 [24.5 – 35.0]P = 0.0001
Table 2 Pulmonary injury in control (CONT) mice and mice treated with cerulein (CER)
CONTCER
Pancreatic water content (% wet weight) 0.74 [0.71 – 0.76] 0.80 [0.78 - 0.83] P < 0.0001 Pancreatic MPO activity (U/mg tissue dry weight) 322 [125 - 456] 2738 [1978 - 3245] P = 0.0002 Pancreatic necrosis (%) 1.26 [0.5 – 2.3] 27.7 [24.5 – 35.0] P = 0.0001 CONT CER Pulmonary MPO activity (U/mg tissue dry weight) 947 [782 - 1145] 10173 [8710 - 12035] P < 0.0001 Pulmonary permeability index 0.57 [0.5 – 0.8] 3.9 [3.1 - 5.1] P = 0.0002 Pulmonary MPO activity (U/mg tissue dry weight)947 [782 - 1145]10173 [8710 - 12035]P < 0.0001
Pulmonary permeability index0.57 [0.5 – 0.8]3.9 [3.1 - 5.1]P = 0.0002
Table 3 IL-6 and IL-10 concentrations in serum, pancreas, lungs, and livers in control (CONT) mice and mice treated with cerulein (CER)
CONTCER
Serum IL-6 (pg/mL)8.9 [8.7 - 11.4]267.5 [98.0 - 312.0]P = 0.02
Serum Il-10 (pg/mL)11.8 [8.9 - 14.7]18.7 [10.9 - 21.6]P = 0.23
Pancreatic IL-6 (pg/mg protein)1.2 [0.5 - 1.9]8.4 [6.4 - 13.2]P = 0.02
Pancreatic IL-10 (pg/mg protein)0.08 [0.03 - 0.20]0.32 [0.20 - 0.79]P = 0.03
Pulmonary IL-6 (pg/mg protein)1.5 [0.5 - 2.1]3.0 [2.4 - 6.9]P = 0.004
Pulmonary IL-10 (pg/mg protein)0.10 [0.01 - 0.20]0.87 [0.42 - 3.80]P = 0.06
Hepatic IL-6 (pg/mg protein)1.15 [0.80 - 1.60]8.20 [5.60 - 11.52]P = 0.006
Hepatic IL-10 (pg/mg protein)0.12 [0.05 - 0.20]0.43 [0.33 - 0.48]P = 0.06